Financial Advisory Group Alx Oncology Holdings Inc Transaction History
Financial Advisory Group
- $552 Million
- Q1 2024
A detailed history of Financial Advisory Group transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Financial Advisory Group holds 31,417 shares of ALXO stock, worth $49,010. This represents 0.06% of its overall portfolio holdings.
Number of Shares
31,417
Previous 31,417
-0.0%
Holding current value
$49,010
Previous $467,000
25.05%
% of portfolio
0.06%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding ALXO
# of Institutions
101Shares Held
39.7MCall Options Held
134KPut Options Held
17.4K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$15.1 Million14.51% of portfolio
-
Tang Capital Management LLC San Diego, CA4.2MShares$6.56 Million0.65% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.03MShares$6.29 Million1.07% of portfolio
-
Redmile Group, LLC San Francisco, CA3.84MShares$5.99 Million0.46% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$4.19 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $63.6M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...